Cost-effectiveness of 3-dimensional conformal radiotherapy and applicator-based brachytherapy in the delivery of accelerated partial breast irradiation

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 37, Issue 2, 2014, Pages 172-176

  Shah, Chirag ^a   Lanni, Thomas ^b   Wilkinson, John Ben ^b   Jawad, Maha ^b   Wobb, Jessica ^b   Berry, Sameer ^b   Wallace, Michelle ^b   Chen, Peter ^b   Grills, Inga S ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

3 dimensional conformal radiotherapy; Accelerated partial breast irradiation; Breast cancer; Cost efficacy; Outcomes; Reimbursement

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; ADULT; AGED; ARTICLE; BALLOON BASED BRACHYTHERAPY; BRACHYTHERAPY; BREAST CANCER; BREAST DISEASE; BREAST EDEMA; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EDEMA; FAT NECROSIS; FIBROSIS; FOLLOW UP; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; MAJOR CLINICAL STUDY; MASTALGIA; MASTITIS; RADIATION DERMATITIS; SEROMA; TELANGIECTASIA; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; TREATMENT OUTCOME; BREAST NEOPLASMS; COST BENEFIT ANALYSIS; DEVICES; ECONOMICS; FEMALE; MEDICARE; MIDDLE AGED; PROCEDURES; REIMBURSEMENT; TUMOR RECURRENCE; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MEDICARE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME; UNITED STATES;

EID: 84900499253     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318271b16d     Document Type: Article

References (20)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
2. Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol. 2001;28:400-418.
3. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254-2262.
4. Wu X, Chen VW, Ruiz B, et al. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999. J La State Med Soc. 2003;155:206-213.
5. Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694-702.
6. Shah C, Antonucci JV, Wilkinson JB, et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matchedpair analysis. Radiother Oncol. 2011;100:210-214.
7. DeSantis C, Siegel R, Bandi P, et al. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409-418.
8. Smith GL, Xu Y, Buchholz TA, et al. Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol. 2011;29:157-165.
9. Suh WW, Pierce LJ, Vicini FA, et al. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2005;62:790-796.
10. Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55:302-311.
11. Chen PY, Wallace M, Mitchell C. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76:991-997.
12. Shah C, Ghilezan M, Arthur D, et al. Initial clinical experience with multilumen brachytherapy catheters for accelerated partial breast irradiation. Brachytherapy. 2012;11:369-373.
13. Shah C, Wilkinson JB, Shaitelman S, et al. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma. Int J Radiat Oncol Biol Phys. 2011; 81:e547-e551.
14. National Cancer Institute. Common terminology criteria for adverse events v.3.0. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic- applications/docs/ctcaev3.pdf. Accessed March 1, 2012.
15. Shaitelman SF, Kim LH, Grills IS, et al. Predictors of long-term toxicity using three-dimensional conformal external beam radiotherapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;81:788-794.
16. Tengs TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 1995;15: 369-390.
17. Vicini F, Beitsch P, Quiet C. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patient treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;70:808-817.
18. Lewin AA, Derhagopian R, Saigal K, et al. Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012;82:2104-2110.
19. Barnett GC, West CM, Coles CE, et al. Standardized Total Average Toxicity score: a scale-and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies. Int J Radiat Oncol Biol Phys. 2012;82: 1065-1074.
20. Leonard C, Carter D, Kercher J, et al. Prospective trial of accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1291-1298